首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >PNAS Plus: Humanized mouse model supports development function and tissue residency of human natural killer cells
【2h】

PNAS Plus: Humanized mouse model supports development function and tissue residency of human natural killer cells

机译:PNAS Plus:人性化的小鼠模型支持人类自然杀伤细胞的发育功能和组织驻留

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immunodeficient mice reconstituted with a human immune system represent a promising tool for translational research as they may allow modeling and therapy of human diseases in vivo. However, insufficient development and function of human natural killer (NK) cells and T cell subsets limit the applicability of humanized mice for studying cancer biology and therapy. Here, we describe a human interleukin 15 (IL15) and human signal regulatory protein alpha (SIRPA) knock-in mouse on a Rag2−/− Il2rg−/− background (SRG-15). Transplantation of human hematopoietic stem and progenitor cells into SRG-15 mice dramatically improved the development and functional maturation of circulating and tissue-resident human NK and CD8+ T cells and promoted the development of tissue-resident innate lymphoid cell (ILC) subsets. Profiling of human NK cell subsets by mass cytometry revealed a highly similar expression pattern of killer inhibitory receptors and other candidate molecules in NK cell subpopulations between SRG-15 mice and humans. In contrast to nonobese diabetic severe combined immunodeficient Il2rg−/− (NSG) mice, human NK cells in SRG-15 mice did not require preactivation but infiltrated a Burkitt’s lymphoma xenograft and efficiently inhibited tumor growth following treatment with the therapeutic antibody rituximab. Our humanized mouse model may thus be useful for preclinical testing of novel human NK cell-targeted and combinatory cancer immunotherapies and for studying how they elicit human antitumor immune responses in vivo.
机译:用人类免疫系统重建的免疫缺陷小鼠代表了有希望的转化研究工具,因为它们可以在体内模拟和治疗人类疾病。但是,人类自然杀伤(NK)细胞和T细胞亚群的发育和功能不足,限制了人源化小鼠研究癌症生物学和治疗方法的适用性。在这里,我们描述了人类白介素15(IL15)和人类信号调节蛋白alpha(SIRPA)敲入小鼠在Rag2 -/- Il2rg -/-背景上( SRG-15)。将人类造血干细胞和祖细胞移植到SRG-15小鼠中,可显着改善循环和组织驻留的人NK和CD8 + T细胞的发育和功能成熟,并促进组织驻留的先天淋巴样细胞的发育单元(ILC)子集。通过大规模流式细胞仪对人类NK细胞亚群进行分析,发现SRG-15小鼠与人类之间的NK细胞亚群中杀伤抑制受体和其他候选分子的表达模式极为相似。与非肥胖型糖尿病严重合并免疫缺陷的Il2rg -/-(NSG)小鼠相反,SRG-15小鼠中的人NK细胞不需要预激活,但可以浸润Burkitt淋巴瘤异种移植物,并有效抑制了用治疗性抗体利妥昔单抗。因此,我们的人源化小鼠模型可用于新型人NK细胞靶向和联合癌症免疫疗法的临床前测试,以及用于研究它们如何在体内引发人抗肿瘤免疫应答。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号